CNS Pharmaceuticals, Inc.
CNSP- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001729427
In the last 90 days, CNS Pharmaceuticals, Inc. insiders filed 1 open-market purchase and 0 sales; 11 institutions reported holding it in 13F filings for Q2 2026, worth $1.34M in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in CNS Pharmaceuticals, Inc. as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- −1 vs. Q2 2022
- Shares held
- 1.30M
- +69.8K (+5.7%) vs. Q2 2022
- Total value
- $232.0K
- −$111.5K (−32.5%) vs. Q2 2022
- New holders
- 4
- 4 more added
- Sold out
- 5
- 1 more reduced
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CNSP on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 11 | $1.34M |
| Q1 2026 | 12 | $348.7K |
| Q4 2025 | 10 | $652.4K |
| Q3 2025 | 8 | $221.5K |
| Q2 2025 | 11 | $421.8K |
| Q1 2025 | 7 | $55.2K |
| Q4 2024 | 21 | $297.3K |
| Q3 2024 | 14 | $75.3K |
| Q2 2024 | 10 | $227.8K |
| Q1 2024 | 19 | $351.0K |
| Q4 2023 | 16 | $425.3K |
| Q3 2023 | 12 | $131.7K |
| Q2 2023 | 12 | $234.4K |
| Q1 2023 | 13 | $190.5K |
| Q4 2022 | 10 | $335.0K |
| Q3 2022 | 21 | $232.0K |
| Q2 2022 | 23 | $343.5K |
| Q1 2022 | 20 | $589.0K |
| Q4 2021 | 24 | $828.0K |
| Q3 2021 | 20 | $1.44M |
| Q2 2021 | 20 | $2.64M |
| Q1 2021 | 19 | $3.04M |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding CNS Pharmaceuticals, Inc.; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 453,615 | $81.0K | 0.00% | +25,912+6.1% | Added |
| Bank of New York Mellon Corp | 203,548 | $36.0K | 0.00% | 00.0% | Unchanged |
| Virtu Financial LLC | 127,922 | $23.0K | 0.00% | −50,262−28.2% | Reduced |
| Geode Capital Management, LLC | 129,016 | $23.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 90,487 | $16.0K | 0.00% | +90,487 | New |
| Renaissance Technologies LLC | 56,800 | $10.0K | 0.00% | +56,800 | New |
| FSM Wealth Advisors, LLC | 40,000 | $7.00K | 0.01% | 00.0% | Unchanged |
| Northern Trust Corp | 32,094 | $6.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 34,526 | $6.00K | 0.00% | +5,519+19.0% | Added |
| Cambridge Investment Research Advisors, Inc. | 25,250 | $5.00K | 0.00% | 00.0% | Unchanged |
| State Street Corp | 19,645 | $4.00K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 20,000 | $3.00K | 0.00% | 00.0% | Unchanged |
| HighTower Advisors, LLC | 18,000 | $3.00K | 0.00% | +2,000+12.5% | Added |
| Goldman Sachs Group Inc | 18,549 | $3.00K | 0.00% | +18,549 | New |
| Wells Fargo & Company | 12,210 | $2.00K | 0.00% | +14+0.1% | Added |
| Alpha Cubed Investments, LLC | 10,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Prime Capital Investment Advisors, LLC | 10,727 | $2.00K | 0.00% | 00.0% | Unchanged |
| Gradient Investments LLC | 200 | $0 | 0.00% | 00.0% | Unchanged |
| Advisor Group Holdings, Inc. | 10 | $0 | 0.00% | 00.0% | Unchanged |
| Global Retirement Partners, LLC | 1,000 | $0 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 177 | $0 | 0.00% | +177 | New |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −20,721−100.0% | Sold out |
| United Capital Financial Advisers, LLC | 0 | $0 | 0.00% | −18,944−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −15,921−100.0% | Sold out |
| Citigroup Inc | 0 | $0 | 0.00% | −13,400−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −10,384−100.0% | Sold out |
| Urban Wealth Management, LLC | – | – | – | – | Not filed |